Efficacy and safety of apatinib or anlotinib combined with PD-1 inhibitors-based therapy as subsequent-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a real-world retrospective study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of apatinib or anlotinib combined with PD-1 inhibitors-based therapy as subsequent-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a real-world retrospective study.
Authors: Gao J; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China., Xu J; Postgraduate College, Xuzhou Medical University, Xuzhou, China., He Y; Postgraduate College, Xuzhou Medical University, Xuzhou, China., Zong D; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China., Jin T; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China., He X; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
Source: Frontiers in oncology [Front Oncol] 2025 Nov 06; Vol. 15, pp. 1624286. Date of Electronic Publication: 2025 Nov 06 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1624286